Orthofix International N.V. (NASDAQ: OFIX) is one of 84 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its rivals? We will compare Orthofix International N.V. to similar businesses based on the strength of its dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation.

Profitability

This table compares Orthofix International N.V. and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Orthofix International N.V. 1.88% 9.96% 7.32%
Orthofix International N.V. Competitors -130.16% -39.30% -11.12%

Risk & Volatility

Orthofix International N.V. has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Comparatively, Orthofix International N.V.’s rivals have a beta of 1.06, suggesting that their average stock price is 6% more volatile than the S&P 500.

Valuation and Earnings

This table compares Orthofix International N.V. and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Orthofix International N.V. $418.71 million $45.74 million 120.79
Orthofix International N.V. Competitors $827.23 million $159.49 million 36.30

Orthofix International N.V.’s rivals have higher revenue and earnings than Orthofix International N.V.. Orthofix International N.V. is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings and price targets for Orthofix International N.V. and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix International N.V. 0 0 5 0 3.00
Orthofix International N.V. Competitors 162 1104 2434 88 2.65

Orthofix International N.V. currently has a consensus target price of $52.50, indicating a potential upside of 3.49%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.97%. Given Orthofix International N.V.’s rivals higher probable upside, analysts clearly believe Orthofix International N.V. has less favorable growth aspects than its rivals.

Insider and Institutional Ownership

94.4% of Orthofix International N.V. shares are owned by institutional investors. Comparatively, 63.1% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 5.6% of Orthofix International N.V. shares are owned by company insiders. Comparatively, 12.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Orthofix International N.V. beats its rivals on 7 of the 13 factors compared.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.